Foundation Medicine Executive and Leadership Team

Daniel Malarek, the Chief Executive Officer at Foundation Medicine, directs the company's overall strategy and market positioning. Malarek guides the organization's mission to advance precision cancer care through molecular profiling, ensuring alignment with scientific excellence and regulatory leadership. This executive oversees the integration of clinical care and research initiatives, driving the development of new medicines and informed treatment decisions for patients. By fostering collaborations across the cancer community, Daniel Malarek ensures Foundation Medicine remains at the forefront of innovation, enabling broader access to personalized oncology solutions globally. The Chief Executive Officer's leadership focuses on expanding the company's impact and solidifying its role as a pioneer in the field.

Ewa Lipinska-Kowalik, the Senior Executive Administartive Partner To Chief Executive Officer at Foundation Medicine, provides critical support to the Chief Executive Officer's strategic initiatives. Lipinska-Kowalik manages complex scheduling, facilitates key communications, and ensures the efficient operation of the CEO's office. This role is vital for maintaining the momentum of Foundation Medicine's mission in molecular profiling and cancer research. By streamlining administrative processes, Ewa Lipinska-Kowalik enables the Chief Executive Officer to focus on high-level decision-making and external partnerships. The effective coordination of executive activities supports the company's commitment to scientific excellence and regulatory leadership in precision cancer care.

Dominique Schutz, the Head Chief Financial Officer, Corporate Management at Foundation Medicine, directs all financial operations and strategic fiscal planning. Schutz oversees budgeting, financial reporting, and investment strategies, ensuring the company's financial health and sustainable growth. This leadership is crucial for supporting Foundation Medicine's pioneering work in molecular profiling and its expansion of precision cancer care. By managing financial resources effectively, Dominique Schutz enables continued investment in research and development, as well as the scaling of operations to meet global demand. The Chief Financial Officer's expertise underpins the company's ability to set standards for scientific excellence and regulatory leadership in the oncology sector.

Beatriz Garcia-Madrid, the Executive Business Partner To the Chief Operating Officer at Foundation Medicine, enhances operational efficiency and strategic execution. Garcia-Madrid supports the Chief Operating Officer in managing day-to-day operations, coordinating cross-functional projects, and ensuring seamless workflow across departments. This partnership is essential for advancing Foundation Medicine's capabilities in molecular profiling and its commitment to shaping the future of clinical care. By optimizing operational processes, Beatriz Garcia-Madrid contributes directly to the company's ability to empower physicians and researchers. The focus remains on driving operational excellence to support the delivery of precision cancer care and the development of novel therapies.

Jessica Kim, the Executive Administrative Partner To the Chief Operating Officer at Foundation Medicine, provides essential support for operational leadership. Kim manages critical administrative functions, coordinates executive communications, and facilitates the smooth execution of the Chief Operating Officer's directives. This role is integral to maintaining the operational agility required for Foundation Medicine's advancements in molecular profiling. By ensuring efficient administrative support, Jessica Kim allows the Chief Operating Officer to concentrate on strategic operational improvements and the expansion of precision cancer care services. The administrative partnership directly contributes to the company's capacity to deliver on its mission of finding answers and taking action for patients.

Rachel von Staats, the Director, Office of the Chief Operating Officer at Foundation Medicine, enhances the efficiency and strategic execution of operational initiatives. Von Staats manages key projects, supports the Chief Operating Officer in cross-departmental coordination, and ensures operational alignment with company objectives. This position is critical for advancing Foundation Medicine's leadership in molecular profiling and precision cancer care. By streamlining operational workflows and facilitating communication, Rachel von Staats contributes to the company's ability to deliver high-quality services to physicians and researchers. The director's efforts support the overall mission of finding answers and enabling more people to benefit from advanced cancer treatments.

Kierstin Smolinski, the Senior Director, People Operations & Organizational Development Chief of Staff at Foundation Medicine, drives human capital strategy and organizational effectiveness. Smolinski leads initiatives in talent management, employee development, and fostering a culture of innovation aligned with the company's mission. This role is pivotal in supporting Foundation Medicine's growth and its commitment to scientific excellence in molecular profiling. By optimizing people operations and organizational structure, Kierstin Smolinski ensures the company has the talent and framework to advance precision cancer care. The Chief of Staff's focus on organizational development directly impacts the company's ability to empower its partners and employees in the pursuit of better patient outcomes.

Andrew Suchoff, the Chief People Officer at Foundation Medicine, leads the strategy for talent acquisition, development, and employee engagement. Suchoff cultivates a high-performance culture that supports Foundation Medicine's pioneering work in molecular profiling and its mission to advance cancer care. This executive oversees all aspects of human resources, ensuring the company attracts and retains top talent essential for scientific innovation and regulatory leadership. By championing employee well-being and professional growth, Andrew Suchoff strengthens the organization's capacity to drive breakthroughs in precision oncology. The Chief People Officer's commitment to people operations is fundamental to the company's success in empowering its partners and improving patient lives.

Lisa Brien, the Senior Administrative Partner at Foundation Medicine, provides comprehensive administrative support to key leadership functions. Brien manages complex scheduling, coordinates critical communications, and facilitates the smooth execution of executive directives. This role is vital for maintaining operational efficiency and supporting Foundation Medicine's mission in molecular profiling. By ensuring seamless administrative operations, Lisa Brien enables executives to focus on strategic priorities, including advancing precision cancer care and fostering research collaborations. The administrative partnership directly contributes to the company's ability to set standards for scientific excellence and regulatory leadership in the field of oncology.

Tanya Egloff, the Senior Administrative Partner at Foundation Medicine, delivers essential administrative support to executive teams. Egloff manages intricate calendars, coordinates important meetings, and ensures efficient information flow across departments. This function is critical for sustaining the operational momentum of Foundation Medicine's efforts in molecular profiling and cancer research. By providing dedicated administrative assistance, Tanya Egloff empowers leadership to concentrate on strategic objectives, such as developing new medicines and enhancing clinical decision-making for patients. The administrative partnership supports the company's overarching goal of enabling more people worldwide to benefit from precision cancer care.